Search Results

Palbociclib (PD0332991) Isethionate 10mg  | 99.59%

APEXBIO TECHNOLOGY LLC

CDK4/6 inhibitor,highly selective Cell Cycle/Checkpoint|Cyclin-Dependent Kinases

More Information Supplier Page

×

Palbociclib (PD0332991) Isethionate

Palbociclib (PD0332991) Isethionate 25mg  | 99.59%

APEXBIO TECHNOLOGY LLC

CDK4/6 inhibitor,highly selective Cell Cycle/Checkpoint|Cyclin-Dependent Kinases

More Information Supplier Page

×

Palbociclib (PD0332991) Isethionate

Palbociclib (PD0332991) Isethionate 50mg  | 99.59%

APEXBIO TECHNOLOGY LLC

CDK4/6 inhibitor,highly selective Cell Cycle/Checkpoint|Cyclin-Dependent Kinases

More Information Supplier Page

×

Palbociclib (PD0332991) Isethionate

Linsitinib 10mM (in 1mL DMSO)  | 99.13%

APEXBIO TECHNOLOGY LLC

IGF1R/IR inhibitor,potent and novel Tyrosine Kinase|Insulin Receptor

More Information Supplier Page

×

Linsitinib

Linsitinib Evaluation Sample  | 99.13%

APEXBIO TECHNOLOGY LLC

IGF1R/IR inhibitor,potent and novel Tyrosine Kinase|Insulin Receptor

More Information Supplier Page

×

Linsitinib

Linsitinib 5mg  | 99.13%

APEXBIO TECHNOLOGY LLC

IGF1R/IR inhibitor,potent and novel Tyrosine Kinase|Insulin Receptor

More Information Supplier Page

×

Linsitinib

Linsitinib 10mg  | 99.13%

APEXBIO TECHNOLOGY LLC

IGF1R/IR inhibitor,potent and novel Tyrosine Kinase|Insulin Receptor

More Information Supplier Page

×

Linsitinib

Linsitinib 50mg  | 99.13%

APEXBIO TECHNOLOGY LLC

IGF1R/IR inhibitor,potent and novel Tyrosine Kinase|Insulin Receptor

More Information Supplier Page

×

Linsitinib

Canagliflozin 500mg  | 99.77%

APEXBIO TECHNOLOGY LLC

SGLT2 inhibitor,potent and selective Metabolism|SGLT

More Information Supplier Page

×

Canagliflozin

Canagliflozin 100mg  | 99.77%

APEXBIO TECHNOLOGY LLC

SGLT2 inhibitor,potent and selective Metabolism|SGLT

More Information Supplier Page

×

Canagliflozin